DuPont Decomposition

Why does RADIOCITY earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

-6.8% = -14.4% × 0.35 × 1.34

Latest: FY2025

Profitability

Net Margin

-14.4%

-3.4% →-14.4%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

0.35x

0.26x →0.35x

Revenue per ₹ of assets

Leverage

Equity Multiplier

1.34x

1.08x →1.34x

Assets funded by equity vs debt

Trend Analysis

ROE declined by 5.9 pp over 4 years. Driven by net margin declining (-3.4% → -14.4%), leverage rising (1.08x → 1.34x).

Historical Decomposition

Last 4 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20220Cr-0Cr-3.4%0.261.08-0.9%
FY20230Cr0Cr1.7%0.301.250.7%
FY20240Cr0Cr3.0%0.341.281.3%
FY20250Cr-0Cr-14.4%0.351.34-6.8%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for RADIOCITY

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.